A presenilin 1 mutation (ser169pro) associated with early-onset AD and myoclonic seizures

Neurology

Volumn 52, Issue 3, 1999, Pages 566-570

  Ezquerra, M ^c   Carnero, C ^a   Blesa, R ^b   Gelpi J L ^c   Ballesta, F ^c   Oliva, Rafael ^b  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

PRESENILIN 1;

ADULT; ALZHEIMER DISEASE; ARTICLE; BRAIN BIOPSY; BRAIN SCINTISCANNING; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; ELECTROENCEPHALOGRAM; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GENETIC LINKAGE; HISTOPATHOLOGY; HUMAN; MYOCLONUS; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEIZURE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0033010135     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.52.3.566     Document Type: Article

References (39)

1. Sherrington R, Rogaev E, Liang Y, et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 1995;375:754-760.
2. Cruts M, Hendriks L, Van Broeckhoven C. The presenilin genes: a new gene family involved in Alzheimer disease pathology. Hum Mol Genet 1996;5:1449-1455.
3. Levy-Lahad E, Wasco W, Yu C, et al. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 1995;269:678-680.
4. Goate A, Chartier-Harlin MC, Giufra L, et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer disease. Nature 1991;349:704-709.
5. Cruts M, Van Broeckhoven C. Presenilin mutations in Alzheimer's disease. Hum Mutat 1998;11:183-190.
6. Hutton M, Busfield F, Wragg M, et al. Complete analysis of the presenilin 1 gene in early onset Alzheimer's disease. Neuroreport 1996;7:801-805.
7. Gómez-Isla T, Wasco W, Pettingell W. A novel presenilin mutation: increased β-amyloid and neurofibrillary changes. Ann Neurol 1997;41:809-813.
8. Aldudo J, Bullido MJ, Arbizu T, Oliva R, Valdivieso F. Identification of a novel mutation (Leu282Arg) of the presenilin 1 gene. Neurosci Lett 1998;240:174-176.
9. Levitan D, Greenwald I. Facilitation of lin-12 mediated signaling by sel-12, a Caenorhabditis elegans s182 Alzheimer's disease gene. Nature 1995;377:351-354.
10. Wragg M, Hutton M, Talbot C, et al. Genetic association between intron polymorphism in presenilin-1 gene and late-onset Alzheimer's disease. Lancet 1996;347:509-512.
11. Ezquerra M, Blesa R, Tolosa E, et al. The genotype 2/2 of the presenilin-1 polymorphism is decreased in Spanish early-onset Alzheimer's disease. Neurosci Lett 1997;227:201-204.
12. Montero J, Arbizu R, Ferrer I, Aguilar M, Peres-Serra J. Clinical and pathologic study of an early case of Alzheimer's disease. Med Clin (Barc) 1977;69:515-518.
13. Blesa R, Adroer R, Santacruz P, Ascaso C, Tolosa E, Oliva R. High apolipoprotein E epsilon 4 allele frequency in age-related memory decline. Ann Neurol 1996;39:548-551.
14. Bernstein FC, Koetzle TF, Williams GJ, et al. The Proteins Data Bank: a computer-based archival file for macromolecular structures. J Mol Biol 1977;112:535-542.
15. Murgolo NJ, Brown JE, Bayne ML, Strader CD. Presenilins mutations in Alzheimer's disease: molecular models suggest a potential functional locus. Trends in Protein Science 1996;17: 389-393.
16. Dauber-Osguthorpe P, Roberts VA, Osguthorpe DJ, Wolff J, Genest MG, Hagler AT. Structure and energetics of ligand binding to proteins: E. coli dihydrofolate-reductase-trimethoprim, a drug-receptor system. Proteins 1988;4:31-47.
17. Von Heijne G. Proline kinks in transmembrane α-helices. J Mol Biol 1991;218:499-503.
18. Eisenberg D, Weiss R, Terwillinger TC. The helical hydrophobic moment: a measure of the amphiphilicity of a helix. Nature 1982;199:371-374.
19. Li X, Greenwald I. Membrane topology of the C. elegans SEL-12 presenilin. Neuron 1996;17:1015-1021.
20. Woolfson DN, Mortishire-Smith RJ, Williams DH. Conserved positioning of proline residues in membrane-spanning helices of ion-channel proteins. Biochem Biophys Res Commun 1991; 175:733-736.
21. St. George-Hyslop P. Genetics of Alzheimer disease. In: Markesbery W, ed. Neuropathology of dementing disease. London: Edward Arnold Publishers, 1997.
22. Campion D, Brice A, Dumanchin C, et al. A novel presenilin 1 mutation resulting in familial Alzheimer's disease with an onset age of 29 years. Neuroreport 1996;7:1582-1584.
23. Lopera F, Ardilla A, Martínez A, et al. Clinical features of early-onset Alzheimer disease in a large kindred with and E280A presenilin-1 mutation. JAMA 1997;277:793-799.
24. Axelman K, Basun H, Lannfelt L. Wide range of disease onset in a family with Alzheimer disease and a His163Tyr mutation in the presenilin-1 gene. Arch Neurol 1998;55:698-702.
25. Harvey RJ, Ellison D, Hardy H, et al. Chromosome 14 familial Alzheimer's disease: the clinical and neuropathological characteristics of a family with a leucine to serine (L250S) substitution at codon 250 of the presenilin 1 gene. J Neurol Neurosurg Psychiatry 1998;64:44-49.
26. Crook R, Ellis R, Shanks M, et al. Early-onset Alzheimer's disease with a presenilin-1 mutation at the site corresponding to the Volga German presenilin-2 mutation. Ann Neurol 1997; 42:124-128.
27. Fox NC, Kennedy AM, Harvey RJ, et al. Clinicopathological features of familial Alzheimer's disease associated with the M139V mutation in the presenilin 1 gene. Brain 1997;120: 491-501.
28. Melanson M, Nalbantoglu J, Berkovic S, et al. Progressive myoclonus epilepsy in young adults with neuropathologic features of Alzheimer's disease. Neurology 1997;49:1732-1733.
29. Guo Q, Furukawa K, Sopher BL, et al. Alzheimer's PS-1 mutation perturbs calcium homeostasis and sensitizes PC12 cells to death induced by amyloid beta-peptide. Neuroreport 1996; 8:379-383.
30. Keller JN, Guo Q, Holtsberg FW, Bruce-Keller AJ, Mattson MP. Increased sensitivity to mitochondrial toxin-induced apoptosis in neural cells expressing mutant presenilin-1 is linked to perturbed calcium homeostasis and enhanced oxyradical production. J Neurosci 1998;18:4439-4450.
31. Trump BJ, Berezesky IK. Calcium-mediated cell injury and cell death. FASEB J 1995;9:219-228.
32. Verkhratsky A, Toescu EC. Calcium and neuronal ageing. Trends Neurosci 1998;21:2-7.
33. Guo Q, Christakos S, Robinson N, Mattson MP. Calbindin D28k blocks the proapoptotic actions of mutant presenilin 1: reduced oxidative stress and preserved mitochondrial function. Proc Natl Acad Sci USA 1998;95:3227-3232.
34. Guo Q, Robinson N, Mattson MP. Secreted beta-amyloid precursor protein counteracts the proapoptotic action of mutant presenilin-1 by activation of NF-kB and stabilization of calcium homeostasis. J Biol Chem 1998;273:12341-12351.
35. Saito K, Elce JS, Nixon RA, et al. Widespread activation of calcium activated neutral proteinase (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration. Proc Natl Acad Sci USA 1993;90:2628-2632.
36. Siman R, Card JP, Davis LG, et al. Proteolitic processing of beta-amyloid precursor by calpain I. J Neurosci 1990;10: 2400-2411.
37. Wong PC, Zheng H, Chen H, et al. Presenilin 1 is required for Notch1 and DII1 expression in the paraxial mesoderm. Nature 1997;387:288-292.
38. Joutel A, Corpechot C, Ducros A, et al. Notch3 mutations in a CASADIL: a hereditary adult-onset condition causing stroke and dementia. Nature 1996;383:707-710.
39. Li J, Xu M, Zhou H, Ma J, Potter H. Alzheimer presenilins in the nuclear membrane, interphase kinetochores, and centrosomes suggest a role in chromosome segregation. Cell 1997;90: 917-927.